Kolexia
Berghian Anca-Viorica
Anatomie et cytologie
Centre Henri-Becquerel
Rouen, France
31 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Carcinome épidermoïde Cancers du sein inflammatoires Carcinome épidermoïde de la tête et du cou Carcinome canalaire du sein Hypoxie Tumeurs de la tête et du cou Carcinome mammaire in situ

Industries

MSD
10 collaboration(s)
Dernière en 2022
A+A
2 collaboration(s)
Dernière en 2021
Daiichi Sankyo
1 collaboration(s)
Dernière en 2022
DIACEUTICS INC.
1 collaboration(s)
Dernière en 2023

Dernières activités

Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy.
Cancer research communications   26 décembre 2023
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
BMC cancer   03 novembre 2023
871P Detection of circulating tumor DNA in operable loco-regionally advanced HPV-negative head and neck squamous cell carcinoma
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   03 août 2022
Impact of preoperative staging with contrast-enhanced mammography for localized breast cancer management.
The British journal of radiology   09 mars 2022
Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC)
2021 San Antonio Breast Cancer Symposium   15 février 2022
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours.
European radiology   29 janvier 2022
Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients.
Scientific reports   15 décembre 2021
2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France.
Annales de pathologie   12 août 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort.
NPJ breast cancer   16 avril 2021